Executive Insights from the 2026 AWS Life Sciences Symposium
AWS for Industries, April 27,2026
AWS highlights how life sciences organizations are scaling AI through production-ready platforms and a builder mentality.
The blog recaps key insights from the 2026 AWS Life Sciences Symposium, discussing the contrasting narratives around AI success in life sciences - from companies struggling with scaling to others advancing AI-assisted drug candidates into clinical trials.
The article emphasizes two critical themes: building for production from day one and adopting a builder mentality across organizations. Examples include Eli Lilly's Cortex platform with 52 models and Bristol Myers Squibb, Sanofi, and Pfizer leveraging Amazon Bedrock AgentCore. AWS also announced Amazon Bio Discovery, a new AI-powered application that combines computational design and wet-lab validation to accelerate drug discovery.